Search Results - Lin, O. Po

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma

    Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma by Chai, Chee Shee, Liam, Chong Kin, Lin, O. Po, Pang, Yong Kek, Ho, G. F., Alip, A., Wong, C. K., Poh, M. E.

    Published 2019
    Get full text
    Get full text
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib

    Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib... by Chai, Chee Shee, Lin, O. Po, Liam, Chong Kin, Pang, Yong Kek, Ho, G. F., Alip, A., Wong, Chee Kuan, Poh, Mau Ern, Tan, Jiunn Liang

    Published 2019
    Get full text
    Get full text
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: